Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Nature Cardiovascular Research|September 24, 2024
Evolution of translational control and the emergence of genes and open reading frames in human and non-human primate heartsJorge Ruiz-Orera, Duncan C Miller, Johannes Greiner, et al.
Blood Advances|December 22, 2020
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implicationNikolaus Jahn, Tobias Terzer, Eric Sträng, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2016
Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung DiseaseJuliane Rieber, Nasrin Abbassi-Senger, Sonja Adebahr, et al.
Lancet (London, England)|November 15, 2023
Rethinking how development assistance for health can catalyse progress on primary health careTobias Kasper, Gavin Yamey, Sinead Dwyer, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2016
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy"Juliane Rieber, Jan Streblow, Lorenz Uhlmann, et al.
Clinical Lung Cancer|July 23, 2019
Long-term Follow-up and Patterns of Recurrence of Patients With Oligometastatic NSCLC Treated With Pulmonary SBRTJuliane Hörner-Rieber, Denise Bernhardt, Oliver Blanck, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2018
Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacyR J Klement, J Hoerner-Rieber, S Adebahr, et al.
Plos One|January 27, 2018
An AKAP-Lbc-RhoA interaction inhibitor promotes the translocation of aquaporin-2 to the plasma membrane of renal collecting duct principal cellsKatharina Schrade, Jessica Tröger, Adeeb Eldahshan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 8, 2017
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung diseaseS Tanadini-Lang, J Rieber, A R Filippi, et al.
Blood Advances|September 30, 2024
Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurinFrank G Rücker, Lars Bullinger, Sibylle Cocciardi, et al.
Pageof 13